These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 2416852)
21. The immunobiology of leprosy. Kaplan G; Cohn ZA Int Rev Exp Pathol; 1986; 28():45-78. PubMed ID: 3516911 [TBL] [Abstract][Full Text] [Related]
22. Fibronectin in leprosy lesions: observations using monoclonal antibodies to human fibronectin. Narayanan RB; Bhutani LK; Sharma AK; Nath I Indian J Lepr; 1984; 56(3):532-9. PubMed ID: 6597212 [TBL] [Abstract][Full Text] [Related]
23. Mycobacterium leprae-specific protein antigens defined by cloned human helper T cells. Ottenhoff TH; Klatser PR; Ivanyi J; Elferink DG; de Wit MY; de Vries RR Nature; 1986 Jan 2-8; 319(6048):66-8. PubMed ID: 2417123 [TBL] [Abstract][Full Text] [Related]
25. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients. Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851 [TBL] [Abstract][Full Text] [Related]
26. Defective cell-mediated immunity in leprosy: failure of T cells from lepromatous leprosy patients to respond to Mycobacterium leprae is associated with defective expression of interleukin 2 receptors and is not reconstituted by interleukin 2. Mohagheghpour N; Gelber RH; Larrick JW; Sasaki DT; Brennan PJ; Engleman EG J Immunol; 1985 Aug; 135(2):1443-9. PubMed ID: 2989366 [TBL] [Abstract][Full Text] [Related]
27. Immunochemical characterization of Mycobacterium leprae antigens by the SDS-polyacrylamide gel electrophoresis immunoperoxidase technique (SGIP) using patients' sera. Klatser PR; van Rens MM; Eggelte TA Clin Exp Immunol; 1984 Jun; 56(3):537-44. PubMed ID: 6378452 [TBL] [Abstract][Full Text] [Related]
29. In situ locations of Mycobacterium leprae-specific antigens. Immunoelectronoptical studies. Boddingius J; Dijkman H Acta Leprol; 1989; 7 Suppl 1():107-12. PubMed ID: 2503963 [TBL] [Abstract][Full Text] [Related]
30. Genetically restricted suppressor T-cell clones derived from lepromatous leprosy lesions. Modlin RL; Kato H; Mehra V; Nelson EE; Fan XD; Rea TH; Pattengale PK; Bloom BR Nature; 1986 Jul 31-Aug 6; 322(6078):459-61. PubMed ID: 2942780 [TBL] [Abstract][Full Text] [Related]
31. Anti-Mycobacterium leprae monoclonal antibodies cross-react with human skin: an alternative explanation for the immune responses in leprosy. Naafs B; Kolk AH; Chin A Lien RA; Faber WR; Van Dijk G; Kuijper S; Stolz E; Van Joost T J Invest Dermatol; 1990 May; 94(5):685-8. PubMed ID: 1691241 [TBL] [Abstract][Full Text] [Related]
32. Demonstration of mycobacterial antigens in leprosy tissues. Mshana RN; Belehu A; Stoner GL; Harboe M; Haregewoin A Int J Lepr Other Mycobact Dis; 1982 Mar; 50(1):1-10. PubMed ID: 7042609 [TBL] [Abstract][Full Text] [Related]
33. Prevalence and specificity of the enhancing effect of three types of interleukin 2 on T cell responsiveness in 97 lepromatous leprosy patients of mixed ethnic origin. Barnass S; Mace J; Steele J; Torres P; Gervasoni B; Ravioli R; Terencio J; Rook GA; Waters MF Clin Exp Immunol; 1986 Apr; 64(1):41-9. PubMed ID: 2426020 [TBL] [Abstract][Full Text] [Related]
34. Molecular mimicry between HSP 65 of Mycobacterium leprae and cytokeratin 10 of the host keratin; role in pathogenesis of leprosy. Singh I; Yadav AR; Mohanty KK; Katoch K; Bisht D; Sharma P; Sharma B; Gupta UD; Sengupta U Cell Immunol; 2012; 278(1-2):63-75. PubMed ID: 23121977 [TBL] [Abstract][Full Text] [Related]
35. In vitro studies on dermal granulomas of human leprosy: characterization of cells using monoclonal antibodies. Narayanan RB; Girdhar BK; Lavania RK; Sengupta U Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):268-72. PubMed ID: 3088184 [TBL] [Abstract][Full Text] [Related]
36. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients. Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181 [TBL] [Abstract][Full Text] [Related]
37. M. leprae and PPD-triggered T cell lines in tuberculoid and lepromatous leprosy. Shankar P; Agis F; Wallach D; Flageul B; Cottenot F; Augier J; Bach MA J Immunol; 1986 Jun; 136(11):4255-63. PubMed ID: 2422278 [TBL] [Abstract][Full Text] [Related]
38. Immunohistological analysis of in situ expression of mycobacterial antigens in skin lesions of leprosy patients across the histopathological spectrum. Association of Mycobacterial lipoarabinomannan (LAM) and Mycobacterium leprae phenolic glycolipid-I (PGL-I) with leprosy reactions. Verhagen C; Faber W; Klatser P; Buffing A; Naafs B; Das P Am J Pathol; 1999 Jun; 154(6):1793-804. PubMed ID: 10362804 [TBL] [Abstract][Full Text] [Related]
39. Cloned suppressor T cells from a lepromatous leprosy patient suppress Mycobacterium leprae reactive helper T cells. Ottenhoff TH; Elferink DG; Klatser PR; de Vries RR Nature; 1986 Jul 31-Aug 6; 322(6078):462-4. PubMed ID: 2426597 [TBL] [Abstract][Full Text] [Related]
40. Monoclonal antibodies against Mycobacterium leprae and their applications in leprosy research. Sengupta U; Sinha S Indian J Lepr; 1984; 56(4):727-41. PubMed ID: 6398337 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]